Form 8-K - Current report:
SEC Accession No. 0001493152-25-010215
Filing Date
2025-03-13
Accepted
2025-03-13 16:27:27
Documents
14
Period of Report
2025-03-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 67412
2 ex5-1.htm EX-5.1 21142
  Complete submission text file 0001493152-25-010215.txt   271618

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE meds-20250310.xsd EX-101.SCH 3009
4 XBRL LABEL FILE meds-20250310_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE meds-20250310_pre.xml EX-101.PRE 22355
16 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3687
Mailing Address 2420 BRUNELLO TRACE LUTZ FL 33558
Business Address 2420 BRUNELLO TRACE LUTZ FL 33558 (800) 261 0281
Scienture Holdings, Inc. (Filer) CIK: 0001382574 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39199 | Film No.: 25736206
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)